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Regional anaesthesia and chronic renal disease
Abstract
Chronic kidney disease (CKD) has become increasingly prevalent in our
aging patient population, especially because glomerular filtration rate (GFR)
and renal reserve decline progressively as we grow older. The most common
causes of CKD are diabetes mellitus, hypertension and glomerulonephritis.
The aim of this article is to present different regional techniques relevant to
patients with CRF. We also reviewed possible complications and specificities
that should be addressed when administering regional anesthesia.
INTRODUCTION
Chronic kidney disease (CKD) is defined as the presence of kidneydamage (usually detected as urinary albumin excretion of 30 mg/day
or more, or equivalent) or decreased kidney function (defined as a
glomerular filtration rate less than 60 ml/min/1.73 m²) for three or
more months. Recent professional guidelines classify the severity of
chronic kidney disease in five stages, with stage 1 being the mildest and
usually causing few symptoms and stage 5 being a severe illness with
poor life expectancy if untreated. Stage 5 CKD is often called End Stage
Renal Disease (ESRD) and is synonymous with the now outdated
terms chronic kidney failure (CKF) or chronic renal failure (CRF).
A wide range of disorders may develop as a consequence of the loss
of renal function. These include disorders of fluid and electrolyte
balance, such as volume overload, hyperkalemia, metabolic acidosis,
and hyperphosphatemia, as well as abnormalities related to hormonal
or systemic dysfunction, such is anorexia, nausea, vomiting, fatigue,
hypertension, anemia, malnutrition, hyperlipidemia and bone disease.
Platelet dysfunction in chronic kidney disease
From regional anesthesia aspect special attention should be payed in
increased tendency of bleeding in acute and chronic kidney disease (1).
This appears to correlate most closely with prolongation of the bleeding
time, due primarily to impaired platelet function. Anemia, dialysis, the
accumulation of medications due to poor clearance and anticoagula-
tion used during dialysis have some role in causing impaired hemosta-
sis in ESRD. Platelet dysfunction occurs both as result of intrinsic pla-
telet abnormalities and impaired platelet–vessel wall interaction (2, 3).
The normal platelet activation, recruitment, adhesion and aggregation
is defective in advanced renal failure. Dialysis may partially correct
these defects, but cannot totally eliminate them. The hemodialysis pro-
cess itself may in fact contribute to bleeding (4). Hemodialysis is also
associated with thrombosis as a result of chronic platelet activation due
to contact with artificial surfaces during dialysis.
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Clinical experience
Anticoagulation and chronic renal
disease
Renal clearance is the primary mode of elimination
for several anticoagulants, including LMWH (low mole-
cular weight heparin), fondaparinux, and the new oral
factor Xa and IIa inhibitors. Therefore, with reduced
renal function, these drugs may accumulate and may
increase the risk of bleeding, particularly in elderly pa-
tients and those at high risk for bleeding (5). The rela-
tionship between renal impairment and drug accumu-
lation for the various LMWHs appears to be variable and
may be related to the chain length distribution of the
different LMWH preparations (6). Two recent studies in
hospitalized patients, the majority of whom were criti-
cally ill and had creatinine clearances less than 30 mL/min,
have shown no bioaccumulation of dalteparin 5000 U
once daily based on serial anti-factor Xa levels (7). There-
fore, they do not reduce the prophylaxis dose of dalte-
parin in patients with renal insufficiency.
With enoxaparin thromboprophylaxis, we suggest that
30 mg once daily be used. We also suggest that fondapa-
rinux, rivaroxaban and dabigatran be avoided unless fu-
ture evidence demonstrates that these agents can be used
safely in patients with severe renal insufficiency.
Comparison of local and regional
technique for creation AVF
Regional anesthesia is administered to different loca-
tions in patients with CRF. Literature primarily cites
importance of regional anesthesia in creating AV fistulas,
comparing effect on fistula flow in local and regional
anesthesia techniques (8, 9). Approximately 25% of ini-
tial arteriovenous fistula (AVF) placements will fail as a
result of thrombosis or failure to develop adequate vessel
size and blood flow. Fistula maturation is impacted by
patient characteristics and surgical technique, but both
increased vein diameter and high fistula blood flow rates
are the most important predictors of successful AVFs.
Anesthetic techniques used in vascular access surgery
(local anaesthesia and regional blocks) may affect these
characteristics and fistula failure. Significant vasodila-
tion after regional block administration is seen in both
the cephalic and basilic veins. These vasodilatory proper-
ties may assist with AVF site selection. In the intraopera-
tive and postoperative periods, use of a regional block,
compared with other anesthetic techniques, resulted in
significantly increased fistula blood flow. The greater
sympathetic block contributed to vessel dilation and re-
duced vasospasm. Use of regional techniques in AVF con-
struction yielded shorter maturation times, lower failure
rates, and higher patency rates.
Spinal anaesthesia
Neuroaxial block (spinal anesthesia) has it place in
patients with CRF. It is administered whenever there is
an indication because it is logical choice as it avoids the ef-
fects of muscle relaxants, narcotics and potent volatile
anesthetics. Symphatetic blockade is an important consi-
deration when utilizing epidural or spinal anaesthesia. A
high level of blockade can result in a significant drop in
blood pressure and GFR. Careful preoperative fluid load-
ing will help offset the degree of hypotension. It should be
remembered that patients with autonomic neuropathy
will not able to adequately compensate for a fall in blood
pressure as would a normal patient.
As acidosis decreases the central nervous system thres-
hold to the toxic effects of local anaesthestics, the total of
anaesthetic should be decreased by approximately 25 per
cent in the acidotic patient (10). Cardiotoxicity of local
anesthestics has been described; more with bupivacaine
then with levobupivacaine so later should the used (11).
The use of regional anaesthesia in patients with ure-
mic neuropathy is controversial. Neuropathy is a com-
mon complication of end-stage kidney disease (ESKD),
typically presenting as a distal symmetrical process with
greater lower-limb than upper-limb involvement. The
condition is of insidious onset, progressing over months.
and has been estimated to be present in 60%–100% of
patients on dialysis. Neuropathy generally only develops
at glomerular filtration rates of less than 12 ml/min. The
most frequent clinical features reflect large-fiber involve-
ment, with paresthesias, reduction in deep tendon re-
flexes, impaired vibration sense, muscle wasting, and
weakness (12). Most anesthetists will agree that its use is
contraindicated, although some authors differ.
The transverse abdominal plane
(TAP) block
The transverse abdominal plane (TAP) block has pro-
ven effective in reducing opioid requirements and pain
scores for some procedures involving the lower abdominal
wall. In the study of Freir et al. they assessed its efficacy in
patients with end-stage renal failure undergoing cadaveric
renal transplantation (13). The addition of a TAP block to
the analgesia regimen for renal transplantation did not
reduce morphine requirements. Controversial results has
been published in paper by Mukhtar et al, where reduce
dose of opioids has been shown after TAP block.
CAPD and regional anaesthesia
In our institution CAPD catheters are introduced and
removed by laparoscopic technique using spinal anesthe-
sia. We did not have any complications, but patients has
reported shoulder pain, headache, nausea, and discomfort
due to pneumoperitoneum during procedure. In general,
patient cooperation and satisfaction are good. In paper by
Tzovaras et al. identical results has been shown as we had
in our study that were comparing spinal and general
anesthesia during laparoscopic cholecystectomy (15).
Kidney transplantation and regional
anesthesia
The earliest kidney transplants were all done under
regional anesthesia, however the recent trend has been
towards general anesthesia. A small (n=50), randomized,
controlled trial comparing general to regional anesthesia
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found no significant difference in total anesthesia time,
surgical time, or any hemodynamic variables measured
(16), and a subsequently published case series showed a
92% success rate using combined spinal-epidural anes-
thesia and no significant intraoperative hemodynamic
changes (17).
CONCLUSION
Regional anesthesia has it place in patients with CRF.
It is administered whenever there is an indication, be-
cause it is logical choice as it avoids the effects of muscle
relaxants, narcotics and potent volatile anaesthetics. It is
useful to administer brachial plexus block and spinal
anesthesia as standard procedures. Literature increasing-
ly cites transverse abdominal plane (TAP) block, but it is
still not a standard procedure. Also established technique
of spinal anaesthesia is introduced in procedures like
CAPD catheter insertion and kidney transplantation.
Attention should be payed to specificities in patients
with CRF: increased tendency of bleeding, increased
cardio and neuro toxycities of local anesthetic and ure-
mic neuropathy in certain patients.
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